Photo detail

Novocell’s top executive John West says a recent $20 million loan from a state agency comes without the strings attached by banks or other traditional lenders.

Stories this photo appears in:

CIRM Loan to Boost Diabetes Research

Stem cell engineering company Novocell Inc. has an ambitious goal. It aims to bring the first human embryonic stem cell therapy for diabetes into the clinic in just four years.

Tease photo